1756 - Framework for the Ongoing Supply of Lipids
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Region | North East |
| Procedure | open |
| OCID | ocds-h6vhtk-02a207 |
Awards (4)
This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Chemtronica AB shared | · | · | active |
| Croda Europe Ltd shared | · | · | · |
| Merck KGaA, shared | · | · | active |
| Well Healthcare Ltd shared | · | · | · |
description
In response to the Covid-19 Vaccine manufacture programme, CPI wish to establish a preferred supplier list for the supply of Lipids for both GMP and non-GMP projects, to support projects with various requirements. As an indicator of the lipids required please see Lot 1 and Lot 2 .A table is provided containing typical lipids that have been or will be used by CPI. CPI are wanting to establish a relationship with suppliers who can cover a wide range of Lipid supply For more information please see the tender documents at https:// ne1procurementservices.com/
documents
- 1756 - Framework for the Ongoing Supply of Lipids , awardNotice
- 1756 - Framework for the Ongoing Supply of Lipids , contractNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 1 Apr 2021 | Contract award notice (F03) | Earlier regulations | 006806-2021 |
more from Centre for Process Innovation Limited
- Grant Audits · 28 Jan 2026
- Grant Audits · £600,000 · 28 Jan 2026
- Servicing and Support For the GC1 Line · 26 Jan 2026
- Framework for QC Analytical Testing Requirements · £6,000,000 · 22 May 2025
- Pilot Scale Phosphoramidites · 31 Jan 2025
- OMICE Oligonucleotide Synthesis Reagents · £8,000,000 · 8 Jan 2025
- Supply of Chromatography Columns · £1,500,000 · 4 Dec 2024
- Parallel Reactor System · 2 Dec 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.